Lir Life Sciences Corp. (CVE:SKNY)

BRIEF

published on 12/19/2025 at 00:05, 2 months 17 days ago

LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor

Obesity Treatment Health Innovation LIR Life Sciences Scientific Advisor Peter Singer
PRESS RELEASE

published on 12/19/2025 at 00:00, 2 months 17 days ago

LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
LIR Life Sciences Corp. announces Dr. Peter Singer, former WHO advisor, as Scientific Advisor. Focus on global obesity treatments & market making services

Market Making Services Lir Life Sciences Corp. Obesity Treatments Scientific Advisor Dr. Peter Singer
BRIEF

published on 12/12/2025 at 00:05, 2 months 24 days ago

LIR Life Sciences Pursues Needle-Free Obesity Therapy Delivery

Obesity Treatment Provisional Patent Needle-free Delivery GLP/GIP Therapies LIR Life Sciences
PRESS RELEASE

published on 12/12/2025 at 00:00, 2 months 24 days ago

LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence

Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences
BRIEF

published on 12/11/2025 at 00:05, 2 months 25 days ago

Lir Life Sciences Announces New Study on Obesity Therapies

Transdermal Delivery Obesity Therapies Peptide Study GLP/GIP Hormones Needle-free Options
PRESS RELEASE

published on 12/11/2025 at 00:00, 2 months 25 days ago

Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
Lir Life Sciences Corp. announces a new comparative cell-penetrating peptide-based uptake study for GLP/GIP-based obesity therapies, enhancing transdermal delivery options. The study aims to improve treatment adherence and effectiveness for metabolic conditions

Transdermal Delivery Lir Life Sciences Corp. Obesity Therapies GLP/GIP Cell-penetrating Peptides
BRIEF

published on 11/26/2025 at 23:05, 3 months 8 days ago

Lir Life Sciences Engages MCS for Digital Marketing Services

Digital Marketing Investor Relations Strategic Investment Drug Development Currency Impact
PRESS RELEASE

published on 11/26/2025 at 23:00, 3 months 8 days ago

Lir Life Sciences Announces Engagement for IR Services
Lir Life Sciences Corp. engages MCS for online marketing services to enhance brand visibility and attract investors. Company focuses on developing obesity treatments through novel drug delivery methods

Online Marketing Services Lir Life Sciences Corp. MCS Obesity Treatments Drug Delivery Methods
BRIEF

published on 11/10/2025 at 15:05, 3 months 25 days ago

Lir Life Sciences Corp. Completes Acquisition of Lir Life Sciences Inc.

Acquisition Private Placement Leadership Changes Obesity Treatment CEO Change
PRESS RELEASE

published on 11/10/2025 at 15:00, 3 months 25 days ago

Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc.
Lir Life Sciences Corp. completes acquisition of Lir Inc., resumes trading on CSE under 'SKNY' ticker symbol. Dr. Edward Mills appointed CEO alongside new board and management members

Acquisition Board Changes CSE Lir Life Sciences Corp. Dr. Edward Mills

Published on 03/05/2026 at 17:55, 1 hour 12 minutes ago

ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 5 hours 7 minutes ago

EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 5 hours 7 minutes ago

GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 5 hours 7 minutes ago

Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 5 hours 27 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

View all ACCESSWIRE

Published on 03/05/2026 at 18:48, 18 minutes ago

POS-Transaction in Own Shares
Published on 03/05/2026 at 18:17, 49 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 03/05/2026 at 17:57, 1 hour 10 minutes ago

EQS-Adhoc: Delivery Hero SE may redeem convertible bonds in H1 2026 using proceeds from a USD 1.5bn increase of its term loans subject to certain conditions
Published on 03/05/2026 at 17:48, 1 hour 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/05/2026 at 17:45, 1 hour 21 minutes ago

Swiss Prime Site announces the conversion price of its CHF 350 million green convertible bonds due 2032 and the outcome of the incentivized conversion invitation

View all EQS

Published on 03/05/2026 at 18:40, 27 minutes ago

2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:34, 32 minutes ago

Mersen: Number of shares and voting rights as of February 28, 2026
Published on 03/05/2026 at 17:45, 1 hour 22 minutes ago

February 2026
Published on 03/05/2026 at 17:45, 1 hour 22 minutes ago

Cie du Bois Sauvage : Results 2025
Published on 03/05/2026 at 13:20, 5 hours 46 minutes ago

Voting rights

View all LES ECHOS COMFI WIRE

News